Following Shanghai Pharmaceutical Group(Faku) Pharmaceutical Co., Ltd., Shanghai Pharmaceutical Group (Jinzhou) Pharmaceutical Co., Ltd. joined the team. The signing ceremony for the acquisition of Jinzhou Pharmaceutical Co., Ltd. by Shanghai Pharmaceutical Group Liaoning Pharmaceutical Foreign Trade Corporation was held on December 5, 2019 in the conference room on the first floor of our company. Mr. Yuan Kehua, general manager of Shanghai Pharmaceutical Group Liaoning Pharmaceutical Foreign Trade Corporation and members of the leadership team, as well as Mr. Wang Xiaoquan, shareholder of Jinzhou Pharmaceutical Co., Ltd., attended the signing ceremony.
At the signing ceremony, the general manager of the company, Mr. Yuan Kehua, delivered an important speech. He pointed out that under the condition of the changing market environment, the key to success is cooperation. The acquisition of Jinzhou Pharmaceutical Co., Ltd. is an important action which conforms to the development strategy of Liaoning Provincial Platform of Shanghai Pharmaceuticals Group. This reorganization is a major historical opportunity as well as a new starting line for both our company and Jinzhou Pharmaceutical Co., Ltd.
Mr. Wang Xiaoquan expressed that he will firmly support the company’s leadership’s resolution, comply with the agreement and give full play to their advantages based on the agreement, achieve the company’s performance goals, and make the performance to a higher level. Mr. Li Zan, the new chairman of Shanghai Pharmaceutical Group (Jinzhou) Pharmaceutical Co., Ltd., said that he would closely focus on the Western Liaoning development strategy put forward by the head office, take advantage of Jinzhou’s regional advantages, seize market opportunities, and actively contribute to the company’s leap-forward development.
Up to now, Jinzhou Pharmaceutical Co., Ltd. officially changed its name to Shanghai Pharmaceutical Group (Jinzhou) Pharmaceutical Co., Ltd. The general manager Mr. Yuan Kehua emphasized that he would attach great importance to the following group management and provide strong guarantee and support for Shanghai Pharmaceutical Group (Jinzhou) Pharmaceutical Co., Ltd., as well as share the company’s comprehensive resource allocation capabilities, advanced logistics warehousing service capabilities and extensive sales system. At the same time, he expressed the hope that Shanghai Pharmaceutical (Jinzhou) can fully and strictly implement the restructuring reform, as well as operate in accordance with the law and compliance. Under the strategic guidance of Shanghai Pharmaceutical Group, it will base on a new starting point, continue to make breakthrough and innovation, remain true to our original aspiration and forge ahead, live up to its entrustment to empower the new market output and vitality of Liaoning Pharmaceutical Foreign Trade Corporation.
Liaoning Pharmaceutical Foreign Trade Corporation will further promote the strategy of Liaoning Provincial Platform of Shanghai Pharmaceuticals, continue to increase market share and expand the family of Shanghai Pharmaceuticals. It will deepen and solidify the road of development, exploit a new era in the development of the pharmaceutical industry, make contributions to the healthy China and serve for the patients.